Synta Pharmaceuticals Corp. (SNTA) Message Board
-
So for those worried that Snta was going to bail on Asco....I guess you got yor answer. They will be quite busy out there fending off partnership offers.
-
As in out of money? Guess they will just have to tap their friends at Delta Dental
-
How do you know he wasn't? They are not going to disclose that
-
Our former President of Research is BACK at Hospira as of today...... now maybe the doom and gloom can be eliminated. The damage is done.. now the long climb back to $10 plus.....
- Reply to
Did it ever occur to anyone that perhaps Ramachandra was asked to resign?
by factspls88 •May 13, 2013 4:08 PMPossibility... or because he took significantly less than his last job at Hospira, he may still have been looking for a greener pasture. He was earning a fraction of his peak income and the job was far less important than his past employment. Basically he was "under employed at SNTA". Be interesting to see where he surfaces and at what level. If its a significant upgrade, he bailed. In any event, I agree that it wasn't based on flawed data. The quick turnaround smells of mutual dissatisfaction. From what I have read about him, he was a acquired taste and perhaps not a pleasing one at that.
-
Significant day and close. Seems people believe company is not going down the drain and that the data will hold up. Speculators would have dumped it today with the crawl back since Thursday IMHO... two in a row.. bring on Monday
-
Based on the opening, someone listened. Guess Roth was busy on the horn with their clients or someone knows that all is well and it kind of leaked out?
-
Nearly a third of the market value has been wiped out in two days. Even with SEC restrictions, it would seem that the company has an obligation to post some comment. The silence just feeds on rumors that their data is flawed, which I don't believe to be the case. Don't know if they were expecting this response, but they have a history of poor media and public relations going back to last year's posting of interim data when the Street interpreted the data as merely mediocre, when Snta thought it was great. They need to issue a release
-
If you believe in the company ..pick a number.. I did, unfortunately from $8.50 down. Maybe support now at $6.70...we can be hopeful. This sets up all the marbles at ASCO. If they don't hit it out of the park...UGH!
-
No response from the company is scary. I guess they can keep their shelf offering on the back shelf...way back.
-
Unless the company addresses resignation before opening, the bloodbath will drive this down to $5.00. Nothing worse than unsubstantiated rumors.
-
I know that SNTA is not the best and biggest when it comes to PR, but Bruce and company have a boatload of stock to protect. Seems to me they HAVE to come out with an announcement and explanation to prevent further bloodshed. Great opportunity for shorts to cover today. Any opinions on the departure is just guesswork. With a plausible announcement we can be back up to $8.50. Interesting that $8.69 was last big buy by Bruce. Wonder if he is buying...wonder if he can buy so close to ASCO or is window closed?
-
That said, it seems incredibly bullish move. They obviously think they have the goods to support additional subscription at higher prices after Asco. Thanks for heads up. I see this as buying opportunity
-
Thanks. Makes sense. With stock near it's high, probably good time to get ready with shelf offering. Don't think they need money anytime soon.
-
Any thoughts on why we got our butts kicked today when other Bio-techs were up?
-
Looks like smart money wasn't head faked. $9.70-$9.87 was a gift and obviously people agreed. Who cares about earnings.......totally meaningless
-
Talk about nibbling... that's more like a taste testing. $80 commitment....impressive.
-
Curious if any longterm ILI'ers have been buying and what do you actually pay. Volume was up and I'm wondering if it's too soon to nibble and is the price sub 40 cents. 40. 42. Or what? Thanks
- Reply to
“The clinical results presented from the GALAXY-1 trial so far have been encouraging,”
by maggieruffus •Apr 22, 2013 8:03 AMI don't think you can read into insiders not buying more. They've got huge positions and other investments too
- Reply to
“The clinical results presented from the GALAXY-1 trial so far have been encouraging,”
by maggieruffus •Apr 22, 2013 8:03 AMObviously the Street had the same concerns about the meaning. If they could have put "very" in front would have pushed this over10. Last time Snta put out an "encouraging" report about test results, we dropped 2 points. Encouraging obviously means "Luke warm", they should have learned from the past